Complement inhibition with the C5 blocker LFG316 in severe COVID-19

Zelek, Wioleta M., Cole, Jade, Ponsford, Mark J., Harrison, Richard A., Schroeder, Ben E., Webb, Nicholas, Jolles, Stephen, Fegan, Christopher, Morgan, Matt, Wise, Matt P. and Morgan, B. Paul 2020. Complement inhibition with the C5 blocker LFG316 in severe COVID-19. American Journal of Respiratory and Critical Care Medicine 202 (9) , pp. 1304-1308. 10.1164/rccm.202007-2778LE

PDF - Accepted Post-Print Version Available under License Creative Commons Attribution Non-commercial. Download (333kB)

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	American Thoracic Society
ISSN:	1073-449X
Date of First Compliant Deposit:	11 September 2020
Date of Acceptance:	8 September 2020
Last Modified:	25 Feb 2021 02:18
URI:	http://orca.cf.ac.uk/id/eprint/134757

Actions (repository staff only)

Edit Item